Anxiety Medications: What Each Does and When It Fits

Anxiety medications have different jobs. Daily medicines such as SSRIs and SNRIs can reduce ongoing symptoms over weeks. Faster medicines may ease distress sooner but bring different risks. The best choice depends on the anxiety disorder, other health needs, past treatment, and side effects. There is no single best pill for everyone.12

This article is education, not a personal treatment plan. Discuss any medication change with your prescriber.

How do anxiety medications differ?

An anxiety medicine is a drug used to reduce anxiety symptoms or treat an anxiety disorder. Some drugs change symptoms over time. Others act more quickly. A drug’s speed does not tell you how well it will protect your sleep, work, or relationships over the next year.

Think of a house with loose windows during a storm. One repair can stop a window from shaking tonight. A more lasting repair may take longer. The analogy has limits. Anxiety has many causes. Drugs do not repair a broken part of the brain as you would fix a window.

Start with the job you need done. Do you worry most days? Avoid speaking to people? Fear another panic attack? These patterns may call for different care. Our guide to anxiety and panic symptoms can help you describe the pattern.

A plan should also name what better would look like in your life. That might mean sleeping with fewer checks, returning to work, or riding the bus again. Feeling sleepy after a pill is a drug effect. It does not, by itself, show that the anxiety disorder is getting better.

SSRIs and SNRIs are two groups of antidepressants that also treat some forms of anxiety. SSRI means selective serotonin reuptake inhibitor. SNRI means serotonin and norepinephrine reuptake inhibitor. These names describe effects on how nerve cells handle chemical signals. The drug action starts before the full benefit, which may take weeks. This does not mean anxiety comes from one simple chemical shortage.1345

Zoom

Which anxiety medications are used daily or as needed?

Daily treatments and medicines used as needed serve different roles. The table shows broad patterns, not a personal prescription. “Off-label” means the FDA has not approved that specific use. It can still have research support.

Sources: drug labels, regulator information, and reviews below.1345101112131415161718192021222324 Time frames are general, and relief is not guaranteed. “Daily” describes a treatment role. It does not specify the number of doses.

Which drugs are FDA-approved for each anxiety disorder?

Approval belongs to a specific medicine, formulation, age group, and condition. An approval for one disorder does not cover every other one.

Here are common U.S. examples. GAD means generalized anxiety disorder. These are anxiety indications, not each drug’s full list of uses.34511121314152324

Buspirone and hydroxyzine use older, broader anxiety wording. That older wording does not mean these drugs work for each type of anxiety. Their trial evidence also does not show equal benefit across all disorders.141516

Pregabalin has an adult GAD indication in the European Union. U.S. anxiety treatment with pregabalin is off-label. It is a federally controlled Schedule V drug in the United States.1718

This is a practical list of common choices, not every product ever approved. Some extended-release forms have different indications from immediate-release forms. Venlafaxine extended-release tablets are separate products with their own labels. Most list depression and social anxiety. One newer tablet lists depression and GAD. None lists panic disorder.67 Ask the pharmacy or prescriber to check the exact product. Childhood treatment also needs a separate review; adult evidence does not simply transfer to a child.

What is the best daily medicine for anxiety?

For many adults who choose a drug, an SSRI or SNRI is an early option with strong evidence. The diagnosis and your goals matter more than an online ranking.12

A large review by Slee and colleagues compared 89 GAD trials with 25,441 adults. Duloxetine, pregabalin, venlafaxine, and escitalopram reduced symptoms more than placebo and had relatively good acceptability. Acceptability meant how often people left the study for any reason.10

Buspirone, sertraline, fluoxetine, and mirtazapine also had favorable findings. Those estimates came from smaller samples. Quetiapine had a large average symptom effect, but more people stopped it. Paroxetine and benzodiazepines also reduced symptoms, but more people stopped them too. A high symptom score ranking can hide a poor fit for daily life.10

These results cannot tell you which drug will work for you. Studies differ in who joins, how long treatment lasts, and which symptoms get measured. A network review also compares drugs in less direct ways. Two drugs may be compared through their separate placebo trials rather than in one shared trial.

Your prescriber should ask what helped or caused harm in the past. Cost, access, plans for pregnancy, drug or alcohol use, and other health needs matter too. There may be a few good choices. A thoughtful first choice is still a trial with follow-up, not a promise.

Fictional composite: Elena, 29. Elena works rotating shifts and drives home late. She asks for the fastest anxiety pill. During the visit, she explains that worry lasts most of the day. She also wants to stay alert while driving. Her clinician discusses a daily treatment and therapy, then sets goals around sleep and missed shifts. Speed becomes one factor among several.

Why can an SSRI make anxiety feel worse at first?

An SSRI or SNRI can cause early agitation, restless energy, or trouble sleeping. Tell your prescriber if this happens. Severe restlessness, unsafe thoughts, or a major change in behavior should never be dismissed as a normal step toward recovery.23

Antidepressants used for anxiety carry an FDA boxed warning, its strongest warning format. Short-term trials found a higher risk of suicidal thoughts and behaviors in people age 24 and younger. People of all ages need monitoring, especially early in care and after dose changes. Treat any new suicidal thought as urgent, even if it seems small. Agree on who will check in and how to get urgent help.34511121321

You may hear this called activation or jitteriness. How often it happens is hard to pin down. A review of 107 papers found a wide range of rates. Studies did not all define the problem in the same way. That makes a single neat percentage unreliable.25

Early distress can have more than one cause. The medicine may be involved. So may lost sleep, more caffeine, another drug, or the anxiety itself. A clinician also needs to consider a mood switch in someone with bipolar disorder. Sleeping very little while feeling unusually energized, reckless, or driven needs prompt review.3

For mild effects, prescribers may monitor closely or adjust the plan. They may choose a slower increase, a different medicine, or therapy. These are clinical decisions. Slower dose increases and added benzodiazepines are common responses. The review found no strong proof that either one works.225

Our guide to the first weeks of an SSRI explains what to track. Record the symptom, when it began, how strong it is, and whether it affects sleep or safety. You do not have to wait for the next booked visit if symptoms are severe.

Are anxiety doses higher than depression doses?

There is no rule that anxiety always needs a higher dose. The dose ranges often overlap. The starting point, pace of change, and final dose can differ by drug and disorder.35111213

For example, sertraline’s label starts panic and social anxiety treatment lower than adult depression treatment. The upper range can still be the same. Escitalopram has overlapping adult ranges for depression and GAD. More medicine does not always bring more benefit.312

A fair trial includes enough time at a dose you can tolerate. It also includes checking the cause of your symptoms. Missed doses or drugs that interact can affect the result. A clinician may decide to wait, adjust, switch, or add therapy. None of those decisions can be made from the number on the bottle alone.

Tell your prescriber what you can and cannot live with. Sexual effects, nausea, dullness, and weight changes deserve a direct conversation. Staying silent can lead to skipped doses that make both benefit and side effects harder to judge.

Where do buspirone and hydroxyzine fit?

Buspirone is used on a regular schedule for ongoing anxiety. Hydroxyzine can produce effects much sooner. They are different drugs with different evidence and safety limits.1141516

Buspirone does not work as a reliable one-dose rescue. Its older trials mainly involved GAD-like anxiety. It can cause dizziness or nausea, and it has meaningful drug interactions. It does not prevent benzodiazepine withdrawal. Read the full buspirone guide for that drug’s strengths and limits.14

Hydroxyzine is a sedating antihistamine. The Cochrane review found some benefit for GAD, but the five studies included only 884 people and had a high risk of bias. The authors did not support it as a reliable first-line GAD treatment.16

The label says not to use it if you have a long QT interval, which is a heart rhythm finding on an ECG. It also says not to use it in early pregnancy. Sedation and older age can also change the choice. Its label also says anxiety benefit beyond four months has not been assessed in systematic studies. A fast effect is not evidence for years of daily use. See hydroxyzine for anxiety for the detailed safety review.15

When might off-label medicines be considered?

An off-label medicine may be considered when better-supported choices do not fit, or when another illness affects the plan. The reason should be clear, along with the evidence and the extra risks.

Pregabalin has meaningful GAD trial support, but its U.S. anxiety use is off-label. It can cause sleepiness, swelling, and weight gain. Misuse and withdrawal are possible. Breathing risk rises with certain sedatives or an existing breathing problem.1718

Gabapentin is also off-label for anxiety, but it should not be treated as interchangeable with pregabalin. Like pregabalin, it can slow breathing when taken with opioids or other sedatives, or with an existing breathing problem.8 A review found evidence across some anxiety states, with major differences by drug and setting. Benefit around surgery does not prove long-term benefit for everyday GAD.19

Mirtazapine’s anxiety use is off-label. It may enter a discussion when depression, low appetite, or sleep problems also need attention. Sleepiness and weight gain can help one person’s goal and hinder another’s. Its anxiety evidence is smaller than the evidence for several first choices.1021

Quetiapine’s anxiety use is off-label. It can reduce GAD symptoms. It also carries FDA boxed warnings. One covers suicidal thoughts in young people. The other covers a higher risk of death in older adults with dementia-related psychosis. Other risks include weight gain, blood sugar and lipid changes, and unwanted movements. Those risks need a clear reason and monitoring. NICE advises against an antipsychotic for GAD in primary care.220

Beta-blocker use for anxiety is off-label too. These drugs may help selected body symptoms, such as a racing heart or shaky hands. That is a narrower goal than treating a whole anxiety disorder. See propranolol for performance anxiety for the evidence and cautions.1

Does non-addictive mean there is no withdrawal?

No. Addiction, physical dependence, and withdrawal are different. A medicine can cause symptoms when reduced without causing compulsive use or craving.

SSRIs and SNRIs can cause withdrawal, sometimes called discontinuation symptoms. These may include dizziness, nausea, sleep changes, or unusual electric-shock feelings. Abrupt changes can make the problem worse. The plan should be tailored with the prescriber.35

Benzodiazepines add a distinct set of risks. Physical dependence can develop even with prescribed use. Misuse and addiction are also possible. Stopping quickly can cause dangerous withdrawal, including seizures. Alcohol and opioids can greatly increase sedation and breathing risks.22

Physical dependence alone does not show that someone has an addiction. Our guide to benzodiazepine dependence and addiction explains the difference. Anyone considering a change after regular use needs a clinician-guided benzodiazepine taper plan.

Fictional composite: David, 67. David has used a prescribed sedative for months. He feels ashamed when he learns about dependence. His clinician explains that the body can adapt even when someone follows directions. They review falls, alcohol use, and other medicines. They make a gradual, supervised plan while treating his anxiety. The goal is safer care, with no blame.

How long do you stay on anxiety medication?

Treatment often continues after you feel better because symptoms can return. The right duration depends on the disorder, past relapses, remaining symptoms, side effects, and your wishes. NICE advises at least a year if a GAD medicine is effective.2

A review by Batelaan and colleagues included 28 studies with 5,233 people who had improved on antidepressants. During follow-up of up to one year, about 36 in 100 people switched to placebo relapsed. About 16 in 100 who continued medicine relapsed.26

Those are pooled estimates, not your personal odds. The review combined anxiety disorders with OCD and PTSD, and follow-up times varied. It also could not settle the best duration beyond a year. The authors judged that withdrawal probably did not explain the higher relapse rate, because most studies tapered the drug.26 In daily practice, withdrawal and returning illness can still be hard to tell apart.

Use the review on how long to stay on an antidepressant to prepare questions. If stopping becomes the goal, discuss withdrawal and a gradual taper. Feeling better is a reason to review the plan, not to make an abrupt change.

How do you build a useful treatment plan?

Build it around a diagnosis, a daily-life goal, and a clear review point. Medication can work alongside exposure-based therapy when that fits the anxiety disorder.

1. Name the pattern. Describe worry, panic, avoidance, sleep, and how life has changed.
2. Bring the whole list. Include prescriptions, supplements, alcohol, cannabis, and nonprescription sleep or allergy drugs.
3. Choose one or two goals. Use concrete tasks, such as attending a meeting or sleeping without repeated checks.
4. Discuss trade-offs. Ask about driving, sexual effects, falls, heart history, pregnancy, and other health needs.
5. Set follow-up and urgent-call rules. Know who to contact and when benefit can fairly be judged.
6. Plan for later. Agree how to review continued need and how any future reduction will be handled.

At a follow-up visit, bring one example of what has changed. A useful note might say: “I went to the store twice this week. Last month I could not go in.” Another might say: “I sleep longer, but I feel too tired to drive.” Both notes help the clinician judge the balance of help and harm. You do not need a long diary or a perfect score.

Keep track of missed doses too. The reason might be cost, a hard work shift, fear of side effects, or a bottle that ran out. Tell the care team which problem you faced. That lets them work on the cause rather than assume the drug failed. Ask who to call if you cannot get the next refill. A gap in access should not turn into an unplanned stop.

If you want to change the plan, say which part no longer fits. You may value clear thinking more than fast relief, or feel that a side effect costs too much. These goals can change over time. Shared care means you can raise them again.

You can seek care for depression and anxiety even if you have not decided about medication. An assessment should make your options clearer.

What we still don’t know

No test or study can tell each person which drug will work best. Many trials are short. Some leave out people with many health needs or long drug lists. Some off-label choices have much more evidence than others. We also lack one clear rate for early jitters. There is no set time when it is safe for everyone to stop care. These gaps make follow-up part of treatment itself.

When to get help now

Emergency: call 911 or go to the nearest emergency room for trouble breathing, collapse, a seizure, or if someone cannot be woken. A severe reaction with fever, confusion, and stiff or jerking muscles also needs emergency care. Chest pain or pressure that is new, severe, lasts more than a few minutes, or comes with effort also needs emergency care. Call 911 if someone might act on thoughts of suicide or harming others, or cannot stay safe.

Right now, any time: call or text 988 for thoughts of suicide or an emotional crisis. This is the 988 Suicide & Crisis Lifeline. You can also chat at 988lifeline.org.1

Same day: Contact the prescriber for severe restlessness, very little sleep with unusual energy, or a major change in behavior. If new suicidal thoughts appear, call or text 988 first, then tell the prescriber the same day. Do not wait out a serious reaction as “just the first weeks.” Shaking, sweating, or sudden worse anxiety after missing, cutting, or stopping a regularly used benzodiazepine needs care right away. Contact the prescriber now or go to an emergency room.22

Make an appointment: Review ongoing side effects, no meaningful benefit, more frequent as-needed use, or a wish to stop.

Key takeaways

• Match the medicine to the anxiety disorder and your daily-life goals.
• Fast relief and lasting treatment are different goals.
• FDA approvals differ by drug, formulation, condition, and age.
• Off-label options need a clear reason and a review of evidence.
• Non-addictive medicines can still cause harm or withdrawal.
• Severe early symptoms deserve prompt review.
• Plan follow-up and any future medication change with your prescriber.

Frequently asked questions

What is the best medication for anxiety?

There is no single best drug for everyone. SSRIs and SNRIs are common early choices when daily medicine fits the diagnosis. Other health needs, what helped in the past, side effects, cost, and your goals also guide the choice. Ask why the drug fits your type of anxiety. Agree on how you will check progress.

Which anxiety medicines are not addictive?

SSRIs, SNRIs, buspirone, and hydroxyzine do not have the same established addiction risks as benzodiazepines. They still have side effects and interactions. SSRIs and SNRIs can cause withdrawal when reduced, which is different from addiction. “Non-addictive” should start a safety discussion, not end it. Review the exact drug and your health history with the prescriber.

Can I take buspirone only when I feel anxious?

Buspirone is used on a regular schedule and takes several weeks to judge. It is not established as a reliable one-dose treatment for an acute panic attack. If you need help during sudden distress, ask for a plan that matches that need. Do not change the timing or replace another medicine on your own.

Is sertraline FDA-approved for generalized anxiety disorder?

Sertraline’s U.S. label does not list GAD. Its use for GAD is off-label, even though research and guidelines support considering it. The label does include adult panic disorder and social anxiety disorder. Your clinician should explain the off-label use. Ask why it fits and which studies support it for your condition.

Why do I feel worse during the first week?

Early side effects can include nausea, sleep loss, or restless energy. Your original anxiety may also be active. Tell the prescriber what changed and when. Severe restlessness, unsafe thoughts, or unusually high energy with little sleep need prompt review. Do not assume that worsening proves the medicine is working or that you must tolerate it.

Will I need anxiety medication forever?

Some people later stop with a planned, supervised reduction. Others benefit from longer treatment. The choice depends on how well you feel, past relapses, symptoms that remain, side effects, and what you want. In studies, more people relapsed after stopping than after staying on a drug. That finding comes from up to a year of follow-up. It does not set one stop date for all.

Related reading on NP FADY

• Hydroxyzine for Anxiety: How Fast It Works and Its Risks
• Propranolol for Performance Anxiety: Benefits and Risks
• Buspirone (BuSpar) for Anxiety: How It Works, Side Effects, and How It Compares With Benzodiazepines and SSRIs
• Starting an SSRI: The First Weeks, the Real Side Effects, and When to Call
• Benzodiazepines: When the Medicine Becomes Hard to Stop

References

1. National Institute of Mental Health. Mental Health Medications. NIMH patient information.

2. National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. CG113. Published 2011; updated 2020; reviewed September 11, 2026, with update needed and deferred. Recommendations.

3. Allergan. Lexapro (escitalopram) tablets and oral solution: U.S. prescribing information. DailyMed, version posted January 1, 2026. DailyMed label.

4. Eli Lilly and Company. Cymbalta (duloxetine) delayed-release capsules: U.S. prescribing information. DailyMed, version posted August 11, 2025. DailyMed label.

5. Advagen Pharma. Venlafaxine hydrochloride extended-release capsules: U.S. prescribing information. DailyMed, version posted August 26, 2026. DailyMed label.

6. Ajanta Pharma USA. Venlafaxine hydrochloride extended-release tablets: U.S. prescribing information. DailyMed, version posted December 23, 2025. DailyMed label.

7. Almatica Pharma. Venlafaxine besylate extended-release tablets: U.S. prescribing information. DailyMed, version posted November 17, 2025. DailyMed label.

8. Viatris Specialty. Neurontin (gabapentin) capsules, tablets, and oral solution: U.S. prescribing information. DailyMed, version posted August 6, 2026. DailyMed label.

9. ANI Pharmaceuticals. Inderal LA (propranolol) extended-release capsules: U.S. prescribing information. DailyMed, version posted August 31, 2026. DailyMed label.

10. Slee A, Nazareth I, Bondaronek P, et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019;393:768-777. DOI: 10.1016/S0140-6736(18)31793-8. Erratum in Lancet. 2019;393:1698. PubMed abstract.

11. Mylan Pharmaceuticals. Paroxetine tablets: U.S. prescribing information. DailyMed, version posted March 16, 2026. DailyMed label.

12. Viatris Specialty. Zoloft (sertraline) tablets and oral solution: U.S. prescribing information. DailyMed, version posted July 24, 2025. DailyMed label.

13. Dista Products (Eli Lilly). Prozac (fluoxetine) capsules: U.S. prescribing information. DailyMed, version posted January 14, 2026. DailyMed label.

14. Advagen Pharma. Buspirone hydrochloride tablets: U.S. prescribing information. DailyMed, version posted January 8, 2026. DailyMed label.

15. Chartwell RX. Hydroxyzine hydrochloride tablets: U.S. prescribing information. DailyMed, version posted December 12, 2025. DailyMed label.

16. Guaiana G, Barbui C, Cipriani A. Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst Rev. 2010;(12):CD006815. DOI: 10.1002/14651858.CD006815.pub2. Searches through March 2010. Cochrane summary.

17. Viatris Specialty. Lyrica (pregabalin) capsules and oral solution: U.S. prescribing information. DailyMed, version posted September 29, 2025. DailyMed label.

18. European Medicines Agency. Lyrica product information. EU prescribing information.

19. Hong JSW, Atkinson LZ, Al-Juffali N, et al. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: systematic review, meta-analysis, and rationale. Mol Psychiatry. 2022;27(3):1339-1349. DOI: 10.1038/s41380-021-01386-6. Full text.

20. H2-Pharma. Seroquel XR (quetiapine) extended-release tablets: U.S. prescribing information. DailyMed, version posted April 13, 2026. DailyMed label.

21. Organon. Remeron and RemeronSolTab (mirtazapine) tablets: U.S. prescribing information. DailyMed, version posted August 8, 2025. DailyMed label.

22. U.S. Food and Drug Administration. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. September 23, 2020. Safety communication.

23. Pharmacia & Upjohn. Xanax (alprazolam) tablets: U.S. prescribing information. DailyMed, version posted February 26, 2026. DailyMed label.

24. H2-Pharma. Klonopin (clonazepam) tablets: U.S. prescribing information. DailyMed, version posted December 2, 2025. DailyMed label.

25. Sinclair LI, Christmas DM, Hood SD, et al. Antidepressant-induced jitteriness/anxiety syndrome: systematic review. British Journal of Psychiatry. 2009;194:483-490. DOI: 10.1192/bjp.bp.107.048371. PubMed abstract.

26. Batelaan NM, Bosman RC, Muntingh A, et al. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ. 2017;358:j3927. DOI: 10.1136/bmj.j3927. Correction in BMJ. 2017;358:j4461. PubMed abstract.

This article is for education and is not a substitute for care from a qualified health professional. Do not start, stop, or change medication without your prescriber’s guidance. Evidence last checked September 19, 2026.

If you or someone you know is in crisis

• Call 911 or go to your nearest emergency room for any life-threatening emergency.
• 988 Suicide & Crisis Lifeline — call or text 988, or chat at 988lifeline.org, available 24/7, free and confidential. En español: marque 988 y oprima 2, o envíe AYUDA al 988. Deaf or hard of hearing: 988 videophone (ASL) or TTY 711 then 988. Veterans: 988 and press 1, or text 838255.
• Crisis Text Line — text HOME to 741741.
• The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
• National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
• National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
• Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
• San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
• Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
• California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
• NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.